Approved on November 5th 2009 was Romidepsin (trade name Istodax). Romidepsin, previously known by the research codes FK-228, FR-901228 and NSC-630176, is a histone deacetylase (HDAC) inhibitor indicated for the treatment of cutaneous T-cell lymphoma (CTCL)… [...]
|
|||||
|
Fatal error: Cannot redeclare searchengine() (previously declared in /home2/sciencg6/public_html/reactivereports/chemistry-blog/wp-content/themes/atahualpa353/functions.php(532) : eval()'d code:19) in /home2/sciencg6/public_html/reactivereports/chemistry-blog/wp-content/themes/atahualpa353/functions.php(532) : eval()'d code on line 25 | |||||